Companies › O'Neill Institute for National and Global Health Law

O'Neill Institute for National and Global Health Law

Coalition or joint letter Healthcare

O'Neill Institute for National and Global Health Law is listed as a coalition or joint letter in Healthcare. It has co-signed 1 joint letter on 1 proposed federal rule in 2023, most often with the Drug Enforcement Administration.

Type
Coalition or joint letter
Industry
Healthcare
Joint letters co-signed
1
Rules commented on
1
First letter
2023-03-31
Latest letter
2023-03-31
Agencies most often
Drug Enforcement Administration (1)

Activity by year

20231

Letters

2023

Expansion of Induction of Buprenorphine via Telemedicine Encounter

DEA-2023-0028Justice Department, Drug Enforcement Administration · filed 2023-03-31 · co-signed; filed by O'Neill Institute for National and Global Health Law at Georgetown University Law Center